The Coretec Group Inc. (CRTG) 10-Q 15 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	13-May-15
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Registrant Name	3DICON CORP
Entity Central Index Key	1375195
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Trading Symbol	TDCP
Entity Common Stock, Shares Outstanding		811,418,715

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash	$2,747	$34,485
Accounts receivable	5,122	0
Prepaid expenses	9,875	17,149
Total current assets	17,744	51,634
Deferred debt costs, net	12,291	3,125
Deposits-other	2,315	2,315
Total Assets	32,350	57,074
Current liabilities:
Current maturities of convertible notes and debentures payable	402,757	405,791
Warrant exercise advances	10,746	21,591
Accounts payable	417,390	384,639
Accrued salaries	194,840	158,102
Accrued interest on debentures	48,454	36,777
Total current liabilities	1,074,187	1,006,900
Total Liabilities	1,074,187	1,006,900
Stockholders' deficiency:
Preferred stock, Series A convertible, $0.0002 par value, 500,000 shares authorized; 355,000 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively	71	71
Common stock $0.0002 par, 1,500,000,000 shares authorized; 683,131,276 and 539,674,567 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively	136,626	107,935
Additional paid-in capital	20,385,298	20,200,743
Accumulated deficit	-21,563,832	-21,258,575
Total Stockholders' Deficiency	-1,041,837	-949,826
Total Liabilities and Stockholders' Deficiency	$32,350	$57,074

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Preferred Stock, Par or Stated Value Per Share	$0.00	$0.00
Preferred Stock, Shares Authorized	500,000	500,000
Preferred Stock, Shares Issued	355,000	355,000
Preferred Stock, Shares Outstanding	355,000	355,000
Common stock, par	$0.00	$0.00
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	683,131,276	539,674,567
Common stock, shares outstanding	683,131,276	539,674,567

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income:
Sales	$0	$10,000
Grant income	5,122	28,748
Total income	5,122	38,748
Expenses:
Research and development	42,909	60,336
General and administrative	258,846	378,109
Interest	8,624	22,807
Total expenses	310,379	461,252
Net loss	($305,257)	($422,504)
Loss per share:
Basic and diluted	($0.00)	($0.00)
Weighted average shares outstanding, basic and diluted	577,648,385	286,990,688

STATEMENTS_OF_CHANGES_IN_STOCK

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIENCY (USD $)	Total	Stock issued for services	Stock issued for liabilities	Preferred Stock	Preferred Stock	Preferred Stock	Common Stock	Common Stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital	Additional Paid-In Capital	Accumulated Deficit During the Development Stage	Accumulated Deficit During the Development Stage	Accumulated Deficit During the Development Stage
					Stock issued for services	Stock issued for liabilities		Stock issued for services	Stock issued for liabilities		Stock issued for services	Stock issued for liabilities		Stock issued for services	Stock issued for liabilities
Balance at Dec. 31, 2014	($949,826)			$71			$107,935			$20,200,743			($21,258,575)
Balance (in shares) at Dec. 31, 2014				355,000			539,674,567
Warrants and options exercised (in shares)				0			114
Warrants and options exercised	43,546			0			0			43,546			0
Stock issued (in shares)					0	0		15,000,000	22,370,103
Stock issued		22,500	37,500		0	0		3,000	4,474		19,500	33,026		0	0
Debentures converted (in shares)				0			106,086,492
Debentures converted	109,700			0			21,217			88,483			0
Net loss for the year	-305,257			0			0			0			-305,257
Balance at Mar. 31, 2015	($1,041,837)			$71			$136,626			$20,385,298			($21,563,832)
Balance (in shares) at Mar. 31, 2015				355,000			683,131,276

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash Flows from Operating Activities
Net loss	($305,257)	($422,504)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock issued for services	22,500	45,000
Amortization of debt issuance costs	-1,499	33,588
Change in:
Accounts receivable	-5,122	0
Prepaid expenses and other assets	7,274	-8,997
Accounts payable and accrued liabilities	118,666	134,405
Net cash used in operating activities	-163,438	-218,508
Cash Flows from Financing Activities
Proceeds from stock and warrant sales, exercise of warrants and warrant exercise advances	32,700	247,865
Proceeds from issuance of debentures, notes and options	99,000	25,000
Cash paid on debentures	0	-115,680
Net cash provided by financing activities	131,700	157,185
Net change in cash	-31,738	-61,323
Cash, beginning of period	34,485	70,769
Cash, end of period	2,747	9,446
Non-Cash Investing and Financing Activities
Conversion of debentures to common stock (net)	109,701	45,700
Cash paid for interest	283	397
Stock issued to satisfy payables	$37,500	$15,000

Uncertainties_and_Use_of_Estim

Uncertainties and Use of Estimates	3 Months Ended
	Mar. 31, 2015
Uncertainties And Use Of Estimates [Abstract]
Uncertainties and Use of Estimates	Note 1 – Uncertainties and Use of Estimates
	Basis of Presentation
	The accompanying financial statements of 3DIcon Corporation (the “Company”) have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. These financial statements should be read in conjunction with the Company's year-end audited financial statements and related footnotes included in the previously filed 10-K. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company as of March 31, 2015, and the statements of its operations for the three months ended March 31, 2015 and March 31, 2014, and cash flows for the three month periods ended March 31, 2015 and 2014. The results of operations for interim periods may not be indicative of the results which may be realized for the full year.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
	Revenue Recognition
	Revenues from software license fees are accounted for in accordance with Accounting Standards Codification (“ASC”) 985-605, “Software Revenue Recognition”. The Company recognizes sales revenue when (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred or services have been rendered; (iii) the sales price is fixed or determinable; and (iv) collectability is reasonably assured.
	Grant revenue is recognized when earned.
	Recent Accounting Pronouncements
	The following is a summary of recent accounting pronouncements that are relevant to the Company:
	In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The guidance requires an entity to evaluate whether there are conditions or events, in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the financial statements are available to be issued when applicable) and to provide related footnote disclosures in certain circumstances. The guidance is effective for the annual period ending after December 15, 2016, and for annual and interim periods thereafter. Early application is permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-15.
	The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supersedes the revenue recognition requirements in FASB ASC 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations.
	The FASB has issued ASU No. 2014-12, Compensation - Stock Compensation (ASC Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered.. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial position and results of operations.
	Uncertainties
	The accompanying financial statements have been prepared on a going concern basis. The Company is in the development stage and has insufficient revenue and capital commitments to fund the development of its planned product and to pay operating expenses.
	The Company has realized a cumulative net loss of $21,563,832 for the period from inception (January 1, 2001) to March 31, 2015, and a net loss of $305,257 and $422,504 for the three months ended March 31, 2015 and 2014, respectively.
	The ability of the Company to continue as a going concern depends on the successful completion of the Company's capital raising efforts to fund the development of its planned products. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
	Management plans to fund the future operations of the Company with existing cash of $2,747 grants and investor funding with new debentures.  Additionally, under the terms of the Golden State 4.75% Convertible Debenture due on December 31, 2016, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year. In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted.  The warrants are exercisable at $381.50 per share.  The number of warrants exercisable is subject to certain beneficial ownership limitations contained in the 4.75% Convertible Debenture (“the Beneficial Ownership Limitations”).  The Beneficial Ownership Limitations prevent Golden State from converting on the 4.75% Convertible Debenture or exercising warrants if such conversion or exercise would cause Golden State’s holdings to exceed 9.99% of the Company’s issued and outstanding common stock.  Subject to the Beneficial Ownership Limitations and provided that Golden State is able to sell the shares under Rule 144, Golden State is required to convert $85.71 of the 4.75% Convertible Debenture and exercise 857 warrants per month.  Based upon the current stock price, the issued and outstanding shares as of March 31, 2015 and ignoring the impact of the Beneficial Ownership Limitations, the Company may receive up to $327,000 per month in funding for the duration of the debenture from Golden State as a result of warrant exercises. However, due to the Beneficial Ownership Limitations, the Company only received $32,700 in advances from Golden State during the three-month period ended March 31, 2015. Such advances are recorded within warrant exercise advances on the balance sheets when received.
	On July 2, 2013, the Company was awarded a $300,000 grant in the 2013 Oklahoma Applied Research Support competition sponsored by the Oklahoma Center for the Advancement of Science and Technology (“OCAST”). The grant is being used to support the development of the Company’s first Product Platform, which will be the basis for a family of products based on the Company’s CSpace® volumetric 3D display technology.
	Joint Development Agreement with Schott Defense
	As part of the Company’s federal funding strategy, the Company intends to effectively compete by forming interdisciplinary teams with potential strategic partners (large and small), academic and commercial laboratories, and systems integrators providing integrated data visualization solutions. The first of these partnerships was reached in March 2014 when the Company signed a Joint Development Agreement with Schott Defense, a federally focused subsidiary of Schott North America.
	Additionally, the Company is continuing to pursue financing through private offering of debt or common stock.

Sponsored_Research_Agreement_S

Sponsored Research Agreement ("SRA") Common Stock Subject to Put Rights and Call Right	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Sponsored Research Agreement ("SRA") Common Stock Subject to Put Right and Call Right	Note 2 – Sponsored Research Agreement ("SRA") Common Stock Subject to Put Rights and Call Right
	Since April 20, 2002, the Company has entered into a number of SRA’s with the University of Oklahoma (“OU”) as follows:
	Phase I: “Pilot Study to Investigate Digital Holography,” April 20, 2004. The Company paid OU $14,116.
	Phase II: “Investigation of 3-Dimensional Display Technologies,” April 15, 2005, as amended. The Company paid OU $528,843.
	Phase III: “3-Dimensional Display Development.” The Company made partial payment to OU by issuing 121,849 post-split equivalent shares (4,264,707 pre-split shares) with a market price of $290,000 on October 14, 2008 and final payment on December 1, 2010 in the amount of $525,481 of which $40,481 was in cash and 1,685,714 post-split equivalent shares (59,000,000 pre-split) of Company stock (the “Shares”). The Shares are subject to an OU ‘put’ right and a 3Dicon ‘call’ right.
	OU “Put” Rights on the Shares
	First “put” period: December 1, 2012 to November 30, 2013. If the shares (held plus previously sold) are valued at less than $100,000 then OU can “put” one-tenth of the shares for $50,000 plus accrued interest retro-active to December 1, 2012 less the value of sold shares. OU currently holds 1,807,563 post-split shares with a market value of less than $100,000. Under the terms of put rights, the put rights could be exercised by OU and the Company would be obligated to pay OU $50,000.
	Second “put” period: December 1, 2013 to November 30, 2014. If the shares (held & previously sold) are valued at less than $970,000 than OU can “put” the remaining shares for $485,000 plus accrued interest retro-active to December 1, 2012 less the value of shares previously sold or redeemed during the first “put.”
	The “put” periods expired without OU taking any action. The shares have therefore been restored to the equity section of the Balance Sheet as of December 31, 2014 as the shares are no longer subject to the put and call options.
	3DIcon “Call” rights on the Shares
	Commencing December 1, 2012, the Company shall have the right to “call” the shares for an amount equal to $970,000 less the amount (if any) of prior shares by OU including amounts “put” to 3DIcon.
	The SRA also amended the previously existing agreements between the Company and OU such that all intellectual property, including all inventions and or discoveries, patentable or un-patentable, developed before July 28, 2008 by OU under the SRA is owned by OU. All intellectual property, including all inventions and/or discoveries, patentable or un-patentable, developed jointly by the Company and OU at any time is jointly owned by the Company and OU. Finally, all intellectual property developed by the Company after July 28, 2008, including all inventions and or discoveries, patentable or un-patentable, is owned by the Company.

OCAST_Grant

OCAST Grant	3 Months Ended
	Mar. 31, 2015
Oklahoma Center For Advancement Of Science and Technology Grant [Abstract]
OCAST Grant	Note 3 – OCAST Grant
	In July 2013, the Company was awarded a two year grant from OCAST. This is the second $300,000 grant received from OCAST. The first grant was completed in August 2012. This matching grant is for a total of $300,000 and commenced September 1, 2013.  The Company received $5,122 in funding during the three-month period ended March 31, 2015. The funds are being used to support the development of the Company’s first Product Platform, which will be the basis for a family of products based on the Company’s CSpace® volumetric 3D display technology.

Debentures_and_Notes_Payable

Debentures and Notes Payable	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Debentures and Notes Payable	Note 4 – Debentures and Notes Payable
		March 31		December 31,
		2015		2014
	Senior convertible Debentures
	10% Convertible debenture to directors’ due June 2015	$	30,000	$	30,000
	10% Convertible debenture due June 2015		29,007		29,007
	4.75% Convertible debenture due December 2016		64,695		65,095
	5% Convertible note due 2015		34,493		74,502
	10% Convertible bridge notes due August 2015 (net of $1,687 and $2,813 OID)		73,312		147,187
	10% Convertible bridge note to director due June 2015		60,000		60,000
	5% Convertible note due March 2017		30,000		-
	5% Promissory note due March 2016 (net of $6,250 OID)		81,250		-
	Total Debentures Payable	$	402,757	$	405,791
	10% Convertible Debentures to Directors due June 30, 2015
	On June 24, 2013, the Company issued to Victor Keen and Martin Keating, Directors of the Company, (“Directors”) 10% convertible debentures in a principal amount of $15,000 each, due June 26, 2014 and subsequently extended to June 30, 2015. The Directors may elect to convert all or any portion of the outstanding principal amount of the debentures at an exercise price of $0.01 per share. Provided that the debentures are paid in full on or before the maturity date, no interest shall accrue on the unpaid balance of the principal amount. In the event that the debentures are not paid in full on or before the maturity date, interest shall accrue on the unpaid outstanding balance of the principal amount of the debentures from June 26, 2013, until paid, at the fixed rate of ten percent (10%) per annum.
	10% Convertible Debenture due Newton, O'Connor, Turner & Ketchum, due June 30, 2015
	On December 20, 2012, the Company issued to Newton, O'Connor, Turner & Ketchum (“NOTK”) a 10% convertible debenture in a principal amount of $29,007, initially due September 30, 2013 and extended to June 30, 2015.  NOTK may elect to convert all or any portion of the outstanding principal amount of the debenture at an exercise price of $0.02534 per share. The Company was indebted to NOTK for legal services performed for the Company and reimbursement of expenses in rendition of those services for the period ended December 31, 2012. The debenture was issued in settlement of the indebtedness.
	4.75% Convertible Debenture due December 31, 2016
	On November 3, 2006, the Company issued to Golden State a 4.75% convertible debenture in a principal amount of $100,000, due December 31, 2014,   subsequently extended to December 31, 2016 and warrants to buy 28,571 shares of the common stock at an exercise price of $381.50 per share. In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted. During 2015, Golden State converted $400 of the $100,000 debenture into 18,727,884 shares of common stock, exercised warrants to purchase 114 shares of common stock at $381.50 per share based on the formula in the convertible debenture. Additionally Golden State advanced $32,700 against future exercises of warrants of which $43,545 was applied to the exercise of warrants leaving $10,746 of unapplied advances at March 31, 2015. The conversion price for the 4.75% $100,000 convertible debenture is the lesser of (i)$140 or (ii) 80% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion. If Golden State elects to convert a portion of the debenture and, on the day that the election is made, the volume weighted average pre-split price is below $0.70, the Company shall have the right to prepay that portion of the debenture that Golden State elected to convert, plus any accrued and unpaid interest, at 135% of such amount.
	5% Convertible Bridge Notes
	On June 6, 2012 and August 1, 2012, the Company issued and sold convertible promissory notes (the “5% Notes") in aggregate principal amount of $415,000 to JMJ Financial (“JMJ”).  The 5% Notes includes a $40,000 original issue discount (the “OID”) that will be prorated based on the advances actually paid to the Company. During 2015, JMJ earned $13,504 OID and accrued interest.  During 2015, JMJ converted $48,384 of the 5% Notes into 25,000,000 shares of common stock at an average of $0.002 per share based on the formula in the 5% Notes. In addition to the OID, the 5% Notes provides for a one-time interest charge of 5% to be applied to the principal sum advanced.  Pursuant to the terms of 5% Notes, JMJ may, at its election, convert all or a part of the $275,000 note and the $140,000 note into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.15 and $0.35, respectively or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJ’s election to convert. If the Company repays the 5% Notes on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay the 5% Notes on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal. The Company did not repay the 5% Notes within the ninety day period. The principal of the 5% Notes is due one year from the date of each of the principal amounts advanced.
	10% Convertible Debenture due August 2015
	On August 15, 2014, the Company issued and sold to an accredited investor a Convertible Debenture (the “10% Debenture”) in the principal amount of $150,000. The 10% Debenture included a 3% original issue discount. Accordingly, the Company received $145,500 gross proceeds, from which the Company paid legal and fees of $5,000. During 2015, the holder of the 10% Debenture, converted $75,000 of the 10% Debenture into 62,358,608 shares of common stock at an average of $0.0001 per share based on the formula in the 5% Notes. The 10% Debenture has a maturity date of August 15, 2015 and carries a 10% interest rate. Subject to a 4.99% beneficial ownership limitation, the holder of the 10% Debenture may, at any time, elect to convert all or any portion of the outstanding principal amount of the 10% Debenture into shares of Common Stock at a conversion price equal Sixty Five Percent (65%) of the lowest traded VWAP, determined on the then current trading market for the Company’s common stock, for 15 trading days prior to conversion.
	10% Convertible Bridge Note
	On September 11, 2012, the Company issued and sold a Convertible Bridge Note (the “Bridge Note”) in the principal amount of $60,000 to Victor Keen, a director of the Company.  The sale of the Bridge Note included a $10,000 original issue discount. Accordingly, the Company received $50,000 gross proceeds. The Bridge Note matured in 90 days from the date of issuance and, other than the original issue discount, the Bridge Note does not carry interest. However, in the event the Bridge Note is not paid on maturity, all past due amounts will accrue interest at 15% per annum. Upon maturity of the Bridge Note, the holder of the Bridge Note may elect to convert all or any portion of the outstanding principal amount of the Bridge Note into (i) securities sold pursuant to an effective registration statement at the applicable offering price; or (ii) shares of common stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to (a) the date of issuance of the Bridge Note, (b) the maturity date of the Bridge Note, or (c) the first closing date of the securities sold pursuant an effective registration statement. On March 16, 2015, the Company entered into a Fifth Amendment agreement (the “Fifth Keen Amendment”) with Victor Keen, to amend the Keen Bridge note. Pursuant to the Fifth Keen Amendment, Mr. Keen agreed to extend the maturity of the Note from December 31, 2014 to June 30, 2015 and to waive, if any, existing or prior defaults under the Keen Bridge Note or the Keen SPA.
	JMJ March 2015 5% Note
	In March 2015, the Company issued and sold a convertible note (the “March 2015 5% Note") in aggregate Principal Sum of $250,000 to JMJ. The 5% Note includes a $25,000 original issue discount (the “OID”) that will be prorated based on the advances actually paid (the “Principal Sum”) to the Company. During 2015, JMJ advanced $30,000 on the 5% Note. In addition to the OID, the March 2015 5% Note provides for a one-time interest charge of 5% to be applied to the Principal Sum. If the Company repays the 5% Note on or before ninety days from the date of the principal amount advanced, the interest rate will be zero percent. If the Company does not repay the March 2015 5% Note on or before ninety days from the date of the advance, a one-time interest charge of 5% shall be applied to the Principal Sum. Pursuant to the terms of March 2015 5% Note, JMJ may, at its election, convert all or a part of the $250,000 note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to JMJ’s election to convert. The principal of the March 2015 5% Note is due two years from the date of each of the principal amounts advanced.
	Typenex Co-Investment, LLC
	In March 2015, the Company issued and sold a convertible note (the “5% Promissory Note") in aggregate Principal Sum of $87,500 to Typenex Co-Investment, LLC, (“Typenex”).  The 5% Promissory Note includes a $7,500 original issue discount (the “OID”) that will be prorated based on the advances actually paid to the Company. Accordingly during 2015, the Company received $80,000 gross proceeds from which the Company paid legal and documentation fees of $20,000 and placement agent fees of $6,750. In addition to the OID, the 5% Promissory Note provides for a one-time interest charge of 5% to be applied to the principal of the 5% Promissory Note. If the Company repays the 5% Promissory Note on or before ninety days from the date of the principal amount advanced, the interest rate will be zero percent. If the Company does not repay the 5% Promissory Note on or before ninety days from the date of the advance, a one-time interest charge of 5% shall be applied to the Principal Sum. Pursuant to the terms of 5% Promissory Note, Typenex may, at its election, convert all or a part of the $87,500 principal and interest thereon of the 5% Promissory Note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to the election to convert. The principal of the 5% Promissory Note is due one year from the March 2015 effective date.

Common_Stock_and_PaidIn_Capita

Common Stock and Paid-In Capital	3 Months Ended
	Mar. 31, 2015
Common Stock, Including Additional Paid In Capital, Net Of Discount [Abstract]
Common Stock and Paid-In Capital	Note 5 – Common Stock and Paid-In Capital
	Downgraded from the OTCQB to the OTC Pink
	On September 2, 2014, the Company received notification from OTC Markets that because the Company’s common stock, which trades under the symbol TDCP, has not had a minimum closing bid price of $.01 during the last thirty days; it has been downgraded from the OTCQB to the OTC Pink, effective September 3, 2014. On March 26, 2014, OTC Markets had announced a series of rule changes to take place between May 1, 2014 and April 1, 2015. These rules set forth new qualifications and fees for quotation of securities on the various tiers of OTC Markets. One of such changes requires that a company’s stock have a minimum closing bid price of $.01 for at least one day in any consecutive thirty day period to continue being quoted on the OTCQB.
	The Company has the option of filing an application for reinstatement to have its common stock quoted on the OTCQB. The Company’s common stock could be reinstated to the OTCQB commencing at such time as it has had a minimum closing bid price of $.01 for any consecutive 30 day period. The downgrading of the Company’s common stock from the OTCQB to the OCT Pink will have no effect on the common stock’s ability to trade or its DWAC (method of electronic transfer of shares) eligibility.
	Warrants Issued
	As of March 31, 2015, NOTK has warrants outstanding to purchase 125,098 shares of common stock at a price of $3.15 per share that expire on September 30, 2016 and, warrants to purchase 96,024 shares of common stock at a price of $3.15 per share that expire on June 1, 2015.  Golden State has warrants outstanding to purchase 18,595 shares of common stock at a price of $381.50 per share which expires December 31, 2016. Global Capital has warrants outstanding to purchase 300,000 shares of common stock at a price of $0.0032 per shares which expire on March 31, 2019.  Additionally from the preferred stock issuance, there are 9,750,000 warrants outstanding to purchase common shares at $0.0055 per share which expire December 31, 2017 and 9,500,000 warrants outstanding that were issued to Victor Keen, the CEO and Director of the Company, which expire on January 17, 2018.
	Common stock and options issued for services and liabilities
	During the three-month period ended March 31, 2015, shares of common stock totaling 15,000,000 were issued for consulting services for which the Company recognized $22,500 of expense.  Additionally, during the period ending March 31, 2015, shares totaling 22,370,103 were issued to consultants for previous services provided to the Company for which the accounts payable liability was reduced by $37,500.
	Private Placement
	On December 9, 2013 and December 11, 2013 the Company closed on $195,000 in a private placement (the “Private Placement”) contemplated by a Securities Purchase Agreement (the “Securities Purchase Agreement”), dated December 9, 2013, pursuant to which the Company sold 195,000 Units (as defined below) to accredited investors (each, an “Investor” and collectively, the “Investors”), one of whom was Victor Keen, the Company’s Chief Executive Officer and a member of the board of directors of the Company. Accordingly, at the closings, the Company issued (i) 195,000 shares of its newly designated Series A Convertible Preferred Stock (the “Series A Preferred”), and (ii) warrants (“Warrants”) to purchase an aggregate of 9,750,000 shares of Common Stock for gross proceed of $195,000.
	On January 23, 2014, the Company sold to Victor Keen, the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, 190,000 Units for a purchase price of $190,000, as part of the Private Placement (as defined therein) disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 13, 2013. Pursuant to such Private Placement, the Company has now received aggregate proceeds equal to $385,000. Such Private Placement is now closed.
	Under the terms of the Securities Purchase Agreement, the Company sold units (“Units”) consisting of: (i) one share of Series A Convertible Preferred Stock and (ii) Warrants to purchase fifty (50) shares of Common Stock. The purchase price of each Unit was $1.00. The total purchase price of the securities sold in the Private Placement was $385,000.
	The terms of the Series A Convertible Preferred Stock and Warrants are as follows:
	Series A Convertible Preferred Stock
	A total of 500,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred Stock”) have been authorized for issuance under the Certificate of Designation of Preferences, Rights and Limitation of Series A Convertible Preferred Stock of 3DIcon Corporation (the “Certificate of Designation”), which Certificate of Designation was filed with the Secretary of State of the State of Oklahoma on December 11, 2013. The shares of Series A Preferred Stock have a par value of $0.0002 per share (the “Stated Value”), and shall receive a dividend of 6% of their Stated Value per annum. Under the Certificate of Designation, the holders of the Series A Preferred Stock have the following rights, preferences and privileges:
	The Series A Preferred Stock may, at the option of the Investor, be converted at any time after the first anniversary of the issuance of the Series A Preferred Stock or from time to time thereafter into 50,000,000 shares of Common Stock that Such Investor is entitled to in proportion to the 500,000 shares of Series A Preferred so designated in the Certificate of Designation.
	The Series A Preferred Stock will automatically be converted into Common Stock anytime the 5 day average VWAP of the Company’s Common Stock prior to such conversion is equal to $0.05 or more. Such mandatory conversion would be converted by the same method described above for discretionary conversions.
	Except as otherwise required by law, the holders of shares of Series A Preferred Stock shall not have voting rights or powers.
	In the event of any (i) liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or ii) sale, merger, consolidation, reorganization or other transaction that results in a change of control of the Company, each holder of a share of Series A Preferred shall be entitled to receive, subject to prior preferences and other rights of any class or series of stock of the Company senior to the Series A Preferred, but prior and in preference to any distribution of any of the assets or surplus funds of the Company to holders of Common Stock, or any other class or series of stock of the Company junior to the Series A Preferred, an amount equal to the Stated Value plus accrued and unpaid dividends (as adjusted for any stock dividends, combinations or splits with respect to such shares) (the “Preference Amount”). After such payment has been made to the holders of Series A Preferred of the full Preference Amount to which such holders shall be entitled, the remaining net assets of the Company available for distribution, if any, shall be distributed pro rata among the holders of Common Stock. In the event the funds or assets legally available for distribution to the holders of Series A Preferred are insufficient to pay the Preference Amount, then all funds or assets available for distribution to the holders of capital stock shall be paid to the holders of Series A Preferred pro rata based on the full Preference Amount to which they are entitled.
	The Company may not declare, pay or set aside any dividends on shares of any class or series of capital stock of the Company (other than dividends on shares of Common Stock payable in shares of Common Stock) unless the holders of the Series A Preferred Stock shall first receive, or simultaneously receive, a dividend on each outstanding share of Series A Preferred in an amount equal to the dividend per share that such holders would have received had they converted their shares of Series A Preferred into shares of Common Stock immediately prior to the record date for the declaration of the Common Stock dividend in an amount equal to the average VWAP during the 5 trading days prior to the date such dividend is due.
	Warrants
	Each Unit under the Securities Purchase Agreement consists of Warrants entitling the Investor to purchase fifty (50) shares of Common Stock for each share of Series A Preferred purchased by such Investor in the Private Placement, at an initial exercise price per share of $0.0055. The exercise price and number of shares of Common Stock issuable under the Warrants are subject to adjustments for stock dividends, splits, combinations and similar events. On or after the first anniversary of the issuance of the Warrants and prior to close of business on fourth anniversary of the issuance of the Warrants and may be exercised at any time upon the election of the holder, provided however, that an Investor may at any given time convert only up to that number of shares of Common Stock so that, upon conversion, the aggregate beneficial ownership of the Company’s Common Stock (calculated pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of such Investor and all persons affiliated with such Investor, is not more than 4.99% of the Company’s Common Stock then outstanding (subject to adjustment up to 9.99% at the Investor’s discretion upon 61 days’ prior notice).
	The $27,000 estimated fair value of warrants for common stock issued in 2013 was determined using the Black-Scholes option pricing model. The expected dividend yield of $0 is based on the average annual dividend yield at the date issued. Expected volatility of 178% is based on the historical volatility of the stock. The risk-free interest rate of 1.38% is based on the U.S. Treasury Constant Maturity rates as of the issue date. The expected life of the warrants of four years is based on historical exercise behavior and expected future experience.
	The $34,926 estimated fair value of warrants for common stock issued in 2014 was determined using the Black-Scholes option pricing model. The expected dividend yield of $0 is based on the average annual dividend yield at the date issued. Expected volatility of 180% is based on the historical volatility of the stock. The risk-free interest rate of 1.64% is based on the U.S. Treasury Constant Maturity rates as of the issue date. The expected life of the warrants of four years is based on historical exercise behavior and expected future experience.
	Transaction Documents Series A Convertible Preferred Stock
	The Securities Purchase Agreement, the Warrants and Certificate of Designation contain ordinary and customary provisions for agreements of this nature, such as representations, warranties, covenants, and indemnification obligations, as applicable. The foregoing descriptions of the Securities Purchase Agreement and the Warrants do not purport to describe all of the terms and provisions thereof and are qualified in their entirety by reference. The Securities Purchase Agreement and the form of Warrant are filed as Exhibits 4.1 and 10.1, respectively, to the Current Report on Form 8-K filed on December 13, 2013.
	The following summary reflects warrant and option activity for the three-month period ended March 31, 2015:
		Attached		Golden State
		Warrants		Warrants		Options
	Outstanding December 31, 2014		19,771,122		18,595		23,030,274
	Granted/purchased		9,500,000		-		-
	Exercised		-		-114		-
	Cancelled		-		-		-
	Outstanding March 31, 2015		19,771,122		18,481		23,030,274
	Stock options are valued at the date of award, which does not precede the approval date, and compensation cost is recognized in the period the options are granted. Stock options generally become exercisable on the date of grant and expire based on the terms of each grant.
	The estimated fair value of options for common stock granted was determined using the Black-Scholes option pricing model. The expected dividend yield is based on the average annual dividend yield as of the grant date. Expected volatility is based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option is based on historical exercise behavior and expected future experience.

Incentive_Stock_Plan

Incentive Stock Plan	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Incentive Stock Plan	Note 6 – Incentive Stock Plan
	In March 2014, the Company established the 3DIcon Corporation 2014 Equity Incentive Plan (the “2014 EIP”). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2014 EIP shall not exceed fifty million (50,000,000) shares. The shares are included in a registration statement filed March 2014. Shares totaling 6,793,478 were issued from the 2014 EIP during 2015 for services rendered. As of March 31, 2015, there were 750,103 shares available for issuance under the 2014 EIP.
	In March 2015, the Company established the 3DIcon Corporation 2015 Equity Incentive Plan (the “2014 EIP”). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2015 EIP shall not exceed eighty-five million (85,000,000) shares. The shares are included in a registration statement filed March, 2015. Shares totaling 40,119,185 were issued from the 2015 EIP during 2015 for legal and consulting services rendered. There are 44,880,815 shares available for issuance under the 2015 EIP.

Office_Lease

Office Lease	3 Months Ended
	Mar. 31, 2015
Leases [Abstract]
Office Lease	Note 7 – Office Lease
	The Company has an Office Lease that expires to July 31, 2015.   The minimum future lease payment to be paid under the remaining 2015 term is $8,000.

Related_Party_Transaction

Related Party Transaction	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transaction	Note 8 – Related Party Transaction
	3DIcon has engaged the law firm of Newton, O’Connor, Turner & Ketchum as its outside corporate counsel since 2005. John O’Connor, a director of 3DIcon, is the Chairman of Newton, O’Connor, Turner & Ketchum.   During the three-month ending March 31, 2015 and March 31, 2014, the Company incurred legal fees to Newton, O’Connor, Turner & Ketchum in the amount of $1,238, and $1,940, respectively.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 9 – Subsequent Events
	Common stock issued for services and liabilities
	Subsequent to March 31, 2015, Golden State converted $150 of the 4.75% convertible debenture into 13,748,500 shares of common stock at $0.00001 per share and exercised 43 warrants at $381.50 per share for $16,404, advanced $16,350 and applied $16,404 of warrant exercise advances leaving $10,692 in warrant exercise advances under the terms of the securities purchase agreements.
	Subsequent to March 31, 2015, the holder of the 10% Convertible Bridge Note, converted $75,000 of the note into 86,996,336 shares of common stock at $0.0009 under the terms of the securities purchase agreements.
	Subsequent to March 31, 2015, the holder of the 5% Convertible Bridge Note, converted $15,120 of the note into 18,000,000 shares of common stock at $0.00008 under the terms of the securities purchase agreements.
	Subsequent to March 31, 2015, shares of common stock totaling 9,542,560 were issued for 2014 consulting services for which the Company reduced accounts payable by $36,500.

Uncertainties_and_Use_of_Estim1

Uncertainties and Use of Estimates (Policies)	3 Months Ended
	Mar. 31, 2015
Uncertainties And Use Of Estimates [Abstract]
Basis of Presentation	Basis of Presentation
	The accompanying financial statements of 3DIcon Corporation (the “Company”) have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. These financial statements should be read in conjunction with the Company's year-end audited financial statements and related footnotes included in the previously filed 10-K. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company as of March 31, 2015, and the statements of its operations for the three months ended March 31, 2015 and March 31, 2014, and cash flows for the three month periods ended March 31, 2015 and 2014. The results of operations for interim periods may not be indicative of the results which may be realized for the full year.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
Revenue Recognition	Revenue Recognition
	Revenues from software license fees are accounted for in accordance with Accounting Standards Codification (“ASC”) 985-605, “Software Revenue Recognition”. The Company recognizes sales revenue when (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred or services have been rendered; (iii) the sales price is fixed or determinable; and (iv) collectability is reasonably assured.
	Grant revenue is recognized when earned.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	The following is a summary of recent accounting pronouncements that are relevant to the Company:
	In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The guidance requires an entity to evaluate whether there are conditions or events, in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the financial statements are available to be issued when applicable) and to provide related footnote disclosures in certain circumstances. The guidance is effective for the annual period ending after December 15, 2016, and for annual and interim periods thereafter. Early application is permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-15.
	The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supersedes the revenue recognition requirements in FASB ASC 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations.
	The FASB has issued ASU No. 2014-12, Compensation - Stock Compensation (ASC Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered.. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial position and results of operations.
Uncertainties	Uncertainties
	The accompanying financial statements have been prepared on a going concern basis. The Company is in the development stage and has insufficient revenue and capital commitments to fund the development of its planned product and to pay operating expenses.
	The Company has realized a cumulative net loss of $21,563,832 for the period from inception (January 1, 2001) to March 31, 2015, and a net loss of $305,257 and $422,504 for the three months ended March 31, 2015 and 2014, respectively.
	The ability of the Company to continue as a going concern depends on the successful completion of the Company's capital raising efforts to fund the development of its planned products. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
	Management plans to fund the future operations of the Company with existing cash of $2,747 grants and investor funding with new debentures.  Additionally, under the terms of the Golden State 4.75% Convertible Debenture due on December 31, 2016, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year. In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted.  The warrants are exercisable at $381.50 per share.  The number of warrants exercisable is subject to certain beneficial ownership limitations contained in the 4.75% Convertible Debenture (“the Beneficial Ownership Limitations”).  The Beneficial Ownership Limitations prevent Golden State from converting on the 4.75% Convertible Debenture or exercising warrants if such conversion or exercise would cause Golden State’s holdings to exceed 9.99% of the Company’s issued and outstanding common stock.  Subject to the Beneficial Ownership Limitations and provided that Golden State is able to sell the shares under Rule 144, Golden State is required to convert $85.71 of the 4.75% Convertible Debenture and exercise 857 warrants per month.  Based upon the current stock price, the issued and outstanding shares as of March 31, 2015 and ignoring the impact of the Beneficial Ownership Limitations, the Company may receive up to $327,000 per month in funding for the duration of the debenture from Golden State as a result of warrant exercises. However, due to the Beneficial Ownership Limitations, the Company only received $32,700 in advances from Golden State during the three-month period ended March 31, 2015. Such advances are recorded within warrant exercise advances on the balance sheets when received.
	On July 2, 2013, the Company was awarded a $300,000 grant in the 2013 Oklahoma Applied Research Support competition sponsored by the Oklahoma Center for the Advancement of Science and Technology (“OCAST”). The grant is being used to support the development of the Company’s first Product Platform, which will be the basis for a family of products based on the Company’s CSpace® volumetric 3D display technology.
	Joint Development Agreement with Schott Defense
	As part of the Company’s federal funding strategy, the Company intends to effectively compete by forming interdisciplinary teams with potential strategic partners (large and small), academic and commercial laboratories, and systems integrators providing integrated data visualization solutions. The first of these partnerships was reached in March 2014 when the Company signed a Joint Development Agreement with Schott Defense, a federally focused subsidiary of Schott North America.
	Additionally, the Company is continuing to pursue financing through private offering of debt or common stock.

Debentures_and_Notes_Payable_T

Debentures and Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Debentures Payable		March 31		December 31,
		2015		2014
	Senior convertible Debentures
	10% Convertible debenture to directors’ due June 2015	$	30,000	$	30,000
	10% Convertible debenture due June 2015		29,007		29,007
	4.75% Convertible debenture due December 2016		64,695		65,095
	5% Convertible note due 2015		34,493		74,502
	10% Convertible bridge notes due August 2015 (net of $1,687 and $2,813 OID)		73,312		147,187
	10% Convertible bridge note to director due June 2015		60,000		60,000
	5% Convertible note due March 2017		30,000		-
	5% Promissory note due March 2016 (net of $6,250 OID)		81,250		-
	Total Debentures Payable	$	402,757	$	405,791

Common_Stock_and_PaidIn_Capita1

Common Stock and Paid-In Capital (Tables)	3 Months Ended
	Mar. 31, 2015
Common Stock, Including Additional Paid In Capital, Net Of Discount [Abstract]
Warrant and Option Activity	The following summary reflects warrant and option activity for the three-month period ended March 31, 2015:
		Attached		Golden State
		Warrants		Warrants		Options
	Outstanding December 31, 2014		19,771,122		18,595		23,030,274
	Granted/purchased		9,500,000		-		-
	Exercised		-		-114		-
	Cancelled		-		-		-
	Outstanding March 31, 2015		19,771,122		18,481		23,030,274

Uncertainties_and_Use_of_Estim2

Uncertainties and Use of Estimates - Additional Information (Detail) (USD $)	3 Months Ended		171 Months Ended	0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Jul. 02, 2013
Unusual Risk or Uncertainty [Line Items]
Net loss	($305,257)	($422,504)	($21,563,832)
Grant income	5,122	28,748
Warrant [Member]
Unusual Risk or Uncertainty [Line Items]
Warrants outstanding, exercise price	$381.50		$381.50
Oklahoma Center for the Advancement of Science and Technology
Unusual Risk or Uncertainty [Line Items]
Grant income				300,000
Golden State Debentures
Unusual Risk or Uncertainty [Line Items]
Estimated Fair Value Of Warrants	32,700		32,700
4.75% Debenture due December 2016
Unusual Risk or Uncertainty [Line Items]
Conversion or exercise cause Golden State's holdings to exceed of Company's issued and outstanding common stock	9.99%
Grant income	2,747
4.75% Debenture due December 2016 | Golden State Debentures
Unusual Risk or Uncertainty [Line Items]
Convertible Debenture, interest rate	4.75%		4.75%
Receives outstanding shares upon submission of conversion notices	1.00%		1.00%
Warrants outstanding, exercise price	$857		$857
Required amount of Convertible Debenture	85.71
Scenario, Forecast | 4.75% Debenture due December 2016 | Maximum | Golden State Debentures
Unusual Risk or Uncertainty [Line Items]
Funds from Golden State result warrant exercises	$327,000

Sponsored_Research_Agreement_S1

Sponsored Research Agreement ("SRA") Common Stock Subject to Put Rights and Call Right - Additional Information (Detail) (USD $)	0 Months Ended		3 Months Ended		0 Months Ended	1 Months Ended	0 Months Ended
	Dec. 01, 2010	Oct. 14, 2008	Mar. 31, 2015	Mar. 31, 2014	Dec. 01, 2012	Apr. 20, 2004	Apr. 15, 2005
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Amount paid to University of Oklahoma			$42,909	$60,336
Market Value of shares issued to University of Oklahoma for Sponsored Research Agreement		290,000
Proceeds from equity			32,700	247,865
Stockholders equity pre split shares	59,000,000
Put Option | Second Anniversary
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Redemption price of rights			50,000
Put Option | Third Anniversary
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Redemption price of rights			485,000
Call Option | Third Anniversary
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Proceeds from equity					970,000
Maximum | Put Option | Second Anniversary
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Proceeds from equity			100,000
Maximum | Put Option | Third Anniversary
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Proceeds from equity			970,000
Pilot Study to Investigate Digital Holography
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Amount paid to University of Oklahoma						14,116
Investigation of 3-Dimensional Display Technologies
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Amount paid to University of Oklahoma							528,843
3-Dimensional Display Development
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Amount paid to University of Oklahoma	525,481
Shares issued to University of Oklahoma for Sponsored Research Agreement	1,685,714	121,849
Stockholders equity pre split shares		4,264,707
3-Dimensional Display Development | Stock issued for cash
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Amount paid to University of Oklahoma	40,481
University Of Oklahoma
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Shares issued to University of Oklahoma for Sponsored Research Agreement			1,807,563

OCAST_Grant_Additional_Informa

OCAST Grant - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Sep. 01, 2013
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Amount earned from grant	$5,122	$28,748
Grant receivable			$300,000

Debentures_and_Notes_Payable_A

Debentures and Notes Payable - Additional Information (Detail) (USD $)	0 Months Ended	3 Months Ended		0 Months Ended
	Aug. 15, 2014	Mar. 31, 2015	Mar. 31, 2014	Sep. 11, 2012	Nov. 03, 2006	Dec. 20, 2012	Jun. 24, 2013	Aug. 01, 2012
Debt Conversion [Line Items]
Convertible debenture, amount converted		$109,701	$45,700
Conversion rate to closing bid price	65.00%
Warrant
Debt Conversion [Line Items]
Warrants outstanding, exercise price		$381.50
4.75% Debenture due in December 31, 2014
Debt Conversion [Line Items]
Convertible debt, principal amount					100,000
Convertible note, conversion description		The conversion price for the 4.75% $100,000 convertible debenture is the lesser of (i)$140 or (ii) 80% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion.
Warrants to purchase common stock, issued					28,571
Warrants outstanding, exercise price					$381.50
Convertible Debenture, interest rate					4.75%
4.75% Debenture due in December 31, 2014 | If volume weighted average price is below $0.70
Debt Conversion [Line Items]
Debenture, prepay portion in percentage		135.00%
4.75% Debenture due in December 31, 2014 | Golden State
Debt Conversion [Line Items]
Advances on Debenture		100,000
Convertible debenture, amount converted		400
Conversion of convertible debenture, shares issued		18,727,884
Warrants outstanding, exercise price		$381.50
Exercise of warrants to purchase common stock		114
Advance against future exercise of warrants		32,700
4.75% Debenture due in December 31, 2014 | Golden State | Applied to the exercise of warrants
Debt Conversion [Line Items]
Advance against future exercise of warrants		43,545
4.75% Debenture due in December 31, 2014 | Golden State | Unapplied advances
Debt Conversion [Line Items]
Advance against future exercise of warrants		10,746
Newton O Connor Turner And Ketchum 10% Convertible Debenture
Debt Conversion [Line Items]
Convertible debt, principal amount						29,007
Convertible note, conversion price						$0.03
Convertible Debenture, interest rate						10.00%
Victor Keen and Martin Keating 10% convertible debenture
Debt Conversion [Line Items]
Convertible debt, principal amount							15,000
Convertible note, conversion price							$0.01
Convertible Debenture, interest rate							10.00%
5% Convertible Bridge Notes
Debt Conversion [Line Items]
Convertible debt, principal amount								415,000
Convertible note, conversion description		In addition to the OID, the 5% Notes provides for a one-time interest charge of 5% to be applied to the principal sum advanced. Pursuant to the terms of 5% Notes, JMJ may, at its election, convert all or a part of the $275,000 note and the $140,000 note into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.15 and $0.35, respectively or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJs election to convert. If the Company repays the 5% Notes on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay the 5% Notes on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal. The Company did not repay the 5% Notes within the ninety day period. The principal of the 5% Notes is due one year from the date of each of the principal amounts advanced.
Warrants outstanding, exercise price		$0.00
Original issue discount								40,000
Original issue discount collected		13,504
Conversion of convertible debentures into common stock		48,384
Conversion of convertible debentures into common stock, shares		25,000,000
10% Convertible Bridge Note
Debt Conversion [Line Items]
Convertible note, conversion description		Upon maturity of the Bridge Note, the holder of the Bridge Note may elect to convert all or any portion of the outstanding principal amount of the Bridge Note into (i) securities sold pursuant to an effective registration statement at the applicable offering price; or (ii) shares of common stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to (a) the date of issuance of the Bridge Note, (b) the maturity date of the Bridge Note, or (c) the first closing date of the securities sold pursuant an effective registration statement.
Proceeds from notes payable				50,000
Debt Instrument, Unamortized Discount				10,000
10% Convertible Bridge Note | Victor Keen
Debt Conversion [Line Items]
Convertible debt, principal amount				60,000
10% Convertible Debenture due August 2015
Debt Conversion [Line Items]
Convertible debt, principal amount	150,000
Advances on Debenture	145,500
Legal And Documentation Fees	5,000
Convertible Debenture, interest rate	10.00%
Conversion of convertible debentures into common stock		75,000
Conversion of convertible debentures into common stock, shares		62,358,608
Debt Instrument Convertible Beneficial Ownership Limitation Percentage	4.99%
Convertible debenture, conversion price per share		$0.00
Typenex Co Investment LLC [Member]
Debt Conversion [Line Items]
Convertible debt, principal amount		87,500
Convertible note, conversion description		convert all or a part of the $87,500 principal and interest thereon of the 5% Promissory Note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to the election to convert.
Advances on Debenture		80,000
Original issue discount		7,500
Legal And Documentation Fees		20,000
Placement Agent Fees		6,750
JMJ March 2015 5% Note
Debt Conversion [Line Items]
Convertible debt, principal amount		250,000
Convertible note, conversion description		convert all or a part of the $250,000 note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to JMJs election to convert.
Advances on Debenture		30,000
Original issue discount		$25,000

Debentures_and_Notes_Payable_D

Debentures and Notes Payable (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Total Long-term Debentures Payable	$402,757	$405,791
10% Convertible debentures to Directors due June 2015
Debt Instrument [Line Items]
Total Debentures	30,000	30,000
10% Convertible debenture due June 2015
Debt Instrument [Line Items]
Total Debentures	29,007	29,007
4.75% Convertible debenture due December 2016
Debt Instrument [Line Items]
Total Debentures	64,695	65,095
5% Convertible note due 2015
Debt Instrument [Line Items]
Total Debentures	34,493	74,502
10% Convertible bridge notes due August 2015 (net of $1,687 and $2,813 OID)
Debt Instrument [Line Items]
Total Debentures	73,312	147,187
10% Convertible bridge note to director due June 2015
Debt Instrument [Line Items]
Total Debentures	60,000	60,000
5% Convertible note due March 2017
Debt Instrument [Line Items]
Total Debentures	30,000	0
5% Promissory note due March 2016 (net of $6,250 OID)
Debt Instrument [Line Items]
Total Debentures	$81,250	$0

Common_Stock_and_PaidIn_Capita2

Common Stock and Paid-In Capital - Additional Information (Detail) (USD $)	0 Months Ended		1 Months Ended	0 Months Ended		3 Months Ended	12 Months Ended
	Dec. 11, 2013	Dec. 09, 2013	Jan. 23, 2014	Apr. 11, 2013	Oct. 14, 2008	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Conversion Of Stock [Line Items]
Stock issued for consulting services, value					$290,000
Maximum purchase of restricted common shares purchase price per share				$1
Payments for repurchase of private placement	195,000	195,000
Common Stock for gross proceed		195,000
Warrants to purchase of common stock			-50
Purchase price per share			$1
Proceeds from issuance of private placement			385,000
Preferred Stock, Shares Authorized						500,000	500,000
Preferred Stock, Par or Stated Value Per Share						$0.00	$0.00
Stock Issued During Period Shares Conversion Of Convertible Securities			190,000
Conversion Price Of Stock						$0.05
Private Placement
Conversion Of Stock [Line Items]
Stock Issued During Period Shares Conversion Of Convertible Securities			190,000
Total purchase price of the securities sold			385,000
Warrant
Conversion Of Stock [Line Items]
Warrants outstanding, exercise price						$381.50
Stock issued for consulting services, shares		9,750,000
Estimated fair value of options							34,926	27,000
Expected dividend yield							0	0
Expected volatility							180.00%	178.00%
Risk-free interest							1.64%	1.38%
Expected life of option							4 years	4 years
Warrants to purchase of common stock						-50
Common stock outstanding percentage						4.99%
Warrant | Private Placement
Conversion Of Stock [Line Items]
Warrants outstanding, exercise price						$0.01
Warrant | Investor
Conversion Of Stock [Line Items]
Common stock outstanding percentage						9.99%
Common Stock
Conversion Of Stock [Line Items]
Stock Issued During Period Shares Conversion Of Convertible Securities						50,000,000
Series A Convertible Preferred Stock
Conversion Of Stock [Line Items]
Preferred Stock, Shares Authorized						500,000
Preferred Stock, Dividend Rate, Percentage	6.00%
Group Two
Conversion Of Stock [Line Items]
Warrants outstanding						125,098
Group Two | Expire on Sep 30, 2016
Conversion Of Stock [Line Items]
Warrants outstanding, exercise price						$3.15
Group Three
Conversion Of Stock [Line Items]
Warrants outstanding						96,024
Group Three | Expire on June 1, 2015
Conversion Of Stock [Line Items]
Warrants outstanding, exercise price						$3.15
Group Four
Conversion Of Stock [Line Items]
Warrants outstanding						18,595
Group Four | Expire on December 31,2014
Conversion Of Stock [Line Items]
Warrants outstanding, exercise price						$381.50
Group Five
Conversion Of Stock [Line Items]
Warrants outstanding						300,000
Group Five | March 31, 2019
Conversion Of Stock [Line Items]
Warrants outstanding, exercise price						$0.00
Group Six
Conversion Of Stock [Line Items]
Warrants outstanding						9,750,000
Group Six | December 31, 2017
Conversion Of Stock [Line Items]
Warrants outstanding, exercise price						$0.01
Group Seven
Conversion Of Stock [Line Items]
Warrants outstanding						9,500,000
Stock issued for services | Common Stock
Conversion Of Stock [Line Items]
Stock issued for consulting services, shares						15,000,000
Consulting Services
Conversion Of Stock [Line Items]
Stock issued for consulting services, value						22,500
Common stock issued to consultants for previous services provided						22,370,103
Reduction in accounts payable liability						$37,500

Warrant_and_Option_Activity_De

Warrant and Option Activity (Detail)	3 Months Ended
	Mar. 31, 2015
Attached Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding beginning of period	19,771,122
Granted/purchased	9,500,000
Exercised	0
Cancelled	0
Outstanding at end of period	19,771,122
Golden State Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding beginning of period	18,595
Granted/purchased	0
Exercised	-114
Cancelled	0
Outstanding at end of period	18,481
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding beginning of period	23,030,274
Granted/purchased	0
Exercised	0
Cancelled	0
Outstanding at end of period	23,030,274

Incentive_Stock_Plan_Additiona

Incentive Stock Plan - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
2014 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive stock plan, authorized		-50,000,000
Incentive stock plan, issued	6,793,478
Incentive stock plan, shares available for issuance	750,103
2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive stock plan, authorized	-85,000,000
Incentive stock plan, issued	40,119,185
Incentive stock plan, shares available for issuance	44,880,815

Office_Lease_Additional_Inform

Office Lease - Additional Information (Detail) (USD $)	1 Months Ended
	Jul. 24, 2012	Mar. 31, 2015
Lease Agreements Future Minimum Payments Due		$8,000
Second Amendment
Extended lease expiration date	31-Jul-15

Related_Party_Transaction_Addi

Related Party Transaction - Additional Information (Detail) (Newton, O'Connor, Turner & Ketchum, a professional corporation ("NOTK"), USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Newton, O'Connor, Turner & Ketchum, a professional corporation ("NOTK")
Related Party Transaction [Line Items]
Legal fees incurred to Newton	$1,238	$1,940

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Subsequent Event [Line Items]
Expense recognized for common stock shares issued for services	$22,500	$45,000
4.75% Convertible Debenture
Subsequent Event [Line Items]
Number of warrants exercised	43
Warrants exercise price per share	$381.50
Advance payment for future exercise of warrants	16,350
Stock Issued During Period Value Stock Warrants Exercised	16,404
Convertible note, conversion price	$0.00
Debt Conversion Converted Instrument Amount 1	150
Debt Conversion Converted Instrument Shares Issued 1	13,748,500
Warrant Exercise Advance During Period Value	16,404
Warrant Exercise Advance Left Value	10,692
Subsequent Event | 10% Convertible Bridge Note
Subsequent Event [Line Items]
Convertible note, conversion price	$0.00
Debt Conversion Converted Instrument Amount 1	75,000
Debt Conversion Converted Instrument Shares Issued 1	86,996,336
Subsequent Event | 5% Convertible Bridge Note
Subsequent Event [Line Items]
Convertible note, conversion price	$0.00
Debt Conversion Converted Instrument Amount 1	15,120
Debt Conversion Converted Instrument Shares Issued 1	18,000,000
Subsequent Event | Consulting Services
Subsequent Event [Line Items]
Stock Issued During Period Shares Other	9,542,560
Expense recognized for common stock shares issued for services	$36,500